Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongli Yin

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 21, 2016
MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial InfarctionXue Liu, Ying Zhang, Weijie Du, et al.
Molecular and Cellular Biochemistry|May 3, 2024
FYB1-targeted modulation of CAPG promotes AML progressionWenyuan Liu, Hongli Yin, Zhiwei Xie, et al.
Carcinogenesis|February 1, 2024
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genesJuanjuan Yu, Yang Yang, Rongfang Zhou, et al.
European Journal of Pharmacology|August 31, 2020
GDF11 replenishment protects against hypoxia-mediated apoptosis in cardiomyocytes by regulating autophagyLei Jiao, Yingchun Shao, Qi Yu, et al.
Cancer Cell International|February 21, 2024
Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylationXiaomei Wan, Jianwei Wang, Fang Fang, et al.
Cell Death Discovery|April 22, 2024
METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanismJianwei Wang, Hongli Yin, Gen Li, et al.
BMC Cancer|February 16, 2024
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastomaGen Li, Liya Ma, Chenxi Feng, et al.
Neuro-Oncology|June 12, 2024
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferationYanling Chen, Ran Zhuo, Lichao Sun, et al.
Carcinogenesis|August 18, 2025
Core Transcriptional Regulatory Circuit-Regulated IGF2BP3 Stabilizes E2F2 mRNA via m6A Modification in NeuroblastomaPengcheng Yang, Jianwei Wang, Ziheng Wu, et al.
Cellular Signalling|July 14, 2025
KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrestLinbo Cai, Jianwei Wang, Yang Yang, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 21, 2016
MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial InfarctionXue Liu, Ying Zhang, Weijie Du, et al.
Molecular and Cellular Biochemistry|May 3, 2024
FYB1-targeted modulation of CAPG promotes AML progressionWenyuan Liu, Hongli Yin, Zhiwei Xie, et al.
Carcinogenesis|February 1, 2024
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genesJuanjuan Yu, Yang Yang, Rongfang Zhou, et al.
European Journal of Pharmacology|August 31, 2020
GDF11 replenishment protects against hypoxia-mediated apoptosis in cardiomyocytes by regulating autophagyLei Jiao, Yingchun Shao, Qi Yu, et al.
Cancer Cell International|February 21, 2024
Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylationXiaomei Wan, Jianwei Wang, Fang Fang, et al.
Cell Death Discovery|April 22, 2024
METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanismJianwei Wang, Hongli Yin, Gen Li, et al.
BMC Cancer|February 16, 2024
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastomaGen Li, Liya Ma, Chenxi Feng, et al.
Neuro-Oncology|June 12, 2024
Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferationYanling Chen, Ran Zhuo, Lichao Sun, et al.
Carcinogenesis|August 18, 2025
Core Transcriptional Regulatory Circuit-Regulated IGF2BP3 Stabilizes E2F2 mRNA via m6A Modification in NeuroblastomaPengcheng Yang, Jianwei Wang, Ziheng Wu, et al.
Cellular Signalling|July 14, 2025
KIF11 promotes AML progression, and its inhibition by SB-743921 suppresses disease advancement through mitotic G2/M phase arrestLinbo Cai, Jianwei Wang, Yang Yang, et al.
Pageof 6